The Journal of Pediatrics
Volume 149, Issue 1, Supplement , Pages S15-S19 , July 2006

Appropriate compensation of pediatric research participants: Thoughts from an Institute of Medicine committee report

  • Bonnie W. Ramsey, MD

      Affiliations

    • Corresponding Author InformationReprint requests: Dr Bonnie W. Ramsey, Children’s Hospital and Regional Medical Center, 1100 Olive Way, Suite 500, Mailstop: MPW 5-4, Seattle, Washington 98101.

References 

  1. Roberts L . Polio (health workers scramble to contain African epidemic) . Science . 2004;305:24–25
  2. Simone JV . Childhood leukemia (successes and challenges for survivors) . N Engl J Med . 2005;141:166–171
  3. Steinbrook R . Testing medications in children . N Engl J Med . 2002;347:1462–1470
  4. US Food and Drug Administration. Modernization Act of 1997 (FDAMA-1997), section 505A. Available online at: http://www.fda.gov/oc/fdama/default.htm.
  5. US Food and Drug Administration . Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients. Final rule . 1998; (21 CFR Parts 201, 312, 314, and 601). December 2. Available online at: http://www.fda.gov/ohrms/dockets/98fr/120298c.pdf.
  6. Best Pharmaceuticals for Children Act, Pub. L. 107-109, 107th Cong. (January 4, 2002).
  7. Institute of Medicine . Ethical Conduct of Clinical Research Involving Children . Washington, DC: The National Academies Press; 2004;
  8. Department of Health and Human Services . Protection of human subjects(45 CFR 46) . 2001; October 1. Available online at: http://www.access.gpo.gov/nara/cfr/waisidx_01/45cfr46_01.html
  9. US Food and Drug Administration . Protection of human subjects. (21 CFR 50) . 2002; April 1. Available online at: http://www.access.gpo.gov/nara/cfr/waisidx_02/21cfr50_02.html.
  10. Food and Drug Administration, HHS . International Conference on Harmonisation (guidance on E11 clinical investigation of medicinal products in pediatric populations) . Fed Regist . 2000;65(242):78493–78494 Dec 15
  11. Council for International Organizations of Medical Sciences . International Ethical Guidelines for Biomedical Research Involving Human Subjects . 2002; November. Available online at: http://www.cioms.ch/frame_guidelines_nov_2002.htm.
  12. US Food and Drug Administration . Guidance for institutional review boards and clinical investigators . 1998 Update (cooperative research) . Rockville, MD: US Food and Drug Administration; 1998; Available online at: http://www.fda.gov/ohrt/irbs/research.html.
  13. Weise KL , Smith ML , Maschke KJ , Copeland HL . National practices regarding payment to research subjects for participating in pediatric research . Pediatrics . 2002;110:577–582
  14. Dickert N , Emanuel E , Grady C . Paying research subjects (an analysis of current policies) . Ann Intern Med . 2002;136:368–373
  15. American Academy of Pediatrics . Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations . Pediatrics . 1995;95:286–294
  16. CenterWatch clinical trials listing services . Boston: CenterWatch; 2000; Available online at: http://www.centerwatch.com.
  17. Wendler D , Rackoff JE , Emanuel EJ , Grady C . The ethics of paying for children’s participation in research . J Pediatr . 2002;141:166–171
  18. Institute of Medicine . Responsible Research (A Systems Approach to Protecting Research Participants) . Washington, DC: The National Academies Press; 2003;
  19. De Angelis C , Drazen JM , Frizelle FA , Haug C , Hoey J , Horton R , et al.   International Committee of Medical Journal Editors. Clinical trial registration (a statement from the International Committee of Medical Journal Editors) . N Engl J Med . 2004;351(12):1250–1251
  20. Borzekowski DL , Rickert VI , Ipp L , Fortenberry JD . At what price? The current state of subject payment in adolescent . J Adolesc Health . 2003;33:378–384
  21. Broome ME , Richards DJ , Hall JM . Children in research (the experience of ill children and adolescents) . J Fam Nurs . 2001;7:32–49
  22. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research . The Belmont Report (Ethical Principles and Guidelines for the Protection of Human Subjects of Research) . Washington, DC: US Government Printing Office; 1979;
  23. Dickert N , Grady C . Paying research subjects (an analysis of current policies) . N Engl J Med . 1999;341:198–203
  24. US Food and Drug Administration. Orphan drug regulations. (Part 316 Subpart C Section 316.3). Available online at: http://www.fda.gov/Orphan/21cfr316.html.

PII: S0022-3476(06)00371-4

doi: 10.1016/j.jpeds.2006.04.045

The Journal of Pediatrics
Volume 149, Issue 1, Supplement , Pages S15-S19 , July 2006